BIBLIOGRAPHIC RECORD
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Christopher S. Freet; Kirsten Shuler; Sarah Sharfstein Kawasaki; Eric Weintraub; Aaron David Greenblatt; Mat Kladney; Edward V. Nunes; Katrina L. Foster; Lan Kong; Nazia T. Raja-Khan; H. Harrington Cleveland; Patricia S. Grigson; Scott C. Bunce; Timothy R. Brick; Jennifer E. Nyland
- Source of metadata
- OpenAlex
- Year recorded
- 2025
Public identifiers and source
Open the source recordReference
Christopher S. Freet; Kirsten Shuler; Sarah Sharfstein Kawasaki; Eric Weintraub; Aaron David Greenblatt; Mat Kladney; Edward V. Nunes; Katrina L. Foster; Lan Kong; Nazia T. Raja-Khan; H. Harrington Cleveland; Patricia S. Grigson; Scott C. Bunce; Timothy R. Brick; Jennifer E. Nyland. (2025). Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol. https://openalex.org/W4415692559
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-18833ca719c77e7fb95be424d68cfc44/